- ►diabetesjournals.org K Esposito, M Ciotola, D Carleo, B Schisano, … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Compared with 60 control subjects matched for age and sex, patients
with the metabolic syndrome had decreased endothelial function, raised
concentrations of inflammatory markers, and reduced insulin sensitivity. ... Cited by 71 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org PO Szapary, LAT Bloedon, FF Samaha, D Duffy, … - Arteriosclerosis, thrombosis, and vascular biology, 2006 - Am Heart Assoc Methods and Results— Sixty nondiabetic adults with low HDL-C and MetSyn were
randomized to PIO or matching placebo for 12 weeks. PIO increased HDL-C by 15%
and 14% at 6 and 12 weeks, respectively, compared with placebo (P<0.001). ... Cited by 105 - Related articles - All 10 versions
- ►medicinainternacba.com.ar [PDF] - Free from Publisher H Sourij, R Zweiker, TC Wascher - Diabetes Care, 2006 - Am Diabetes Assoc OBJECTIVE—About one of five patients with coronary artery disease (CAD)
suffers from previously unknown, predominantly postprandial type 2 diabetes. In
the process of atherogenesis and the subsequent increased cardiovascular ... Cited by 38 - Related articles - BL Direct - All 8 versions
FF Samaha, PO Szapary, N Iqbal, MM … - Arteriosclerosis, Thrombosis, and Vascular Biology, 2006 - Am Heart Assoc Methods and Results— We performed a prospective, double-blinded,
placebo-controlled study of 60 nondiabetic subjects with low high-density
lipoprotein cholesterol (HDL-C) level and metabolic syndrome to ... Cited by 87 - Related articles - All 9 versions
F Martens… - Journal of cardiovascular pharmacology, 2005 - journals.lww.com To determine whether pioglitazone influences endothelial function directly, we
examined in a randomized, crossover, placebo-controlled, double-blind trial the
effects of 4 weeks of pioglitazone treatment in 20 male type 2 diabetic ... Cited by 51 - Related articles - BL Direct - All 6 versions
- ►onlinejacc.org M Hanefeld, N Marx, A Pfützner, W Baurecht, G … - Journal of the American College of Cardiology, 2007 - Elsevier In a 12-week, prospective, double-blind trial, 125 subjects were randomized to
simvastatin or pioglitazone plus placebo or a simvastatin/pioglitazone
combination. We tested changes in hs-CRP by analysis of covariance. A ... Cited by 71 - Related articles - BL Direct - All 25 versions
T Forst, C Hohberg, SD Fuellert, G Lübben, T … - Hormone and metabolic research, 2005 - cat.inist.fr The role of intact proinsulin and adiponectin in endothelial dysfunction and
insulin resistance has been receiving increasing attention. This study
investigates the effect of PPARγ stimulation or beta-cell stimulation on ... Cited by 25 - Related articles - BL Direct - All 3 versions
G Derosa, A D'Angelo, PD Ragonesi, L … - Journal of Clinical Pharmacy and Therapeutics, 2006 - interscience.wiley.com Methods: This 12-month, multicentre, double-blind, randomized, controlled,
parallel-group trial was conducted at three study sites in Italy. We assessed
patients with type 2 diabetes mellitus (duration ≥6 months) and with ... Cited by 49 - Related articles - BL Direct - All 6 versions
HJ Kim, ES Kang, DJ Kim, SH Kim, CW Ahn, … - CLINICAL ENDOCRINOLOGY-OXFORD-, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 33 - Related articles - BL Direct - All 7 versions
TD Wang, WJ Chen, WC Cheng, JW Lin, MF … - The American journal of cardiology, 2006 - Elsevier The mechanisms by which thiazolidinediones exert beneficial effects on the
endothelium are still not clear. We examined the effects of rosiglitazone on the
plasma markers of metabolic control (glucose, insulin, adiponectin, ... Cited by 24 - Related articles - All 12 versions
